The good and the bad of Ozempic and other semaglutide drugs
The Lab and Valley 101 explore how new diabetes drugs Ozempic and Wegovy are helping people lose weight. The "miracle" drugs also have side effects.
Valley 101 · The Arizona Republic and azcentral.com
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Doctors’ offices and medical spas in Arizona are getting flooded with requests for prescriptions for new drugs.
They originally were approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, but their success in helping people lose weight is what's making them a near-household name. As patients are reporting promising results, word is getting around.
It’s almost impossible to avoid hearing about Ozempic, Wegovy and their active ingredient, semaglutide, in the news or on social media.
But are these new so-called miracle drugs too good to be true? Who are they really for, and how can people get them? This week on The Lab at azcentral, in conjunction with Valley 101, we look into how the drugs work and the reality of how they make people feel.
We spoke with doctors, patients and others to find out why the drugs are different from other weight-loss interventions and why the medications have become divisive, both culturally and socioeconomically.
Learn more about your ad choices. Visit megaphone.fm/adchoices